Clinical Trial of Kanglaite Injection (KLTi) in Advanced Non-Small Cell Lung Cancer (NSCLC)
Status:
Recruiting
Trial end date:
2022-05-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of Kanglaite Injection for
advanced non-small cell lung cancer(NSCLC).
Phase:
Phase 4
Details
Lead Sponsor:
Jie Li
Collaborators:
Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences Ministry of Science and Technology of the People´s Republic of China